Alkermes Future Growth
Future criteria checks 0/6
Alkermes's revenue and earnings are forecast to decline at 2% and 15.5% per annum respectively. EPS is expected to decline by 18% per annum. Return on equity is forecast to be 18.1% in 3 years.
Key information
-15.5%
Earnings growth rate
-18.0%
EPS growth rate
Biotechs earnings growth | 31.5% |
Revenue growth rate | -2.0% |
Future return on equity | 18.1% |
Analyst coverage | Good |
Last updated | 28 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,549 | 329 | 499 | 577 | 9 |
12/31/2025 | 1,523 | 331 | 405 | 527 | 12 |
12/31/2024 | 1,516 | 352 | 410 | 577 | 12 |
12/31/2023 | 1,663 | 519 | 353 | 401 | N/A |
9/30/2023 | 1,591 | 215 | 254 | 295 | N/A |
6/30/2023 | 1,462 | 103 | 159 | 196 | N/A |
3/31/2023 | 1,121 | -164 | -59 | -22 | N/A |
12/31/2022 | 1,112 | -33 | -17 | 21 | N/A |
9/30/2022 | 1,132 | -129 | 14 | 51 | N/A |
6/30/2022 | 1,173 | -94 | 102 | 133 | N/A |
3/31/2022 | 1,201 | -62 | 140 | 169 | N/A |
12/31/2021 | 1,174 | 76 | 73 | 102 | N/A |
9/30/2021 | 1,129 | -92 | 112 | 138 | N/A |
6/30/2021 | 1,100 | -63 | 88 | 115 | N/A |
3/31/2021 | 1,044 | -95 | 48 | 78 | N/A |
12/31/2020 | 1,039 | -111 | 41 | 83 | N/A |
9/30/2020 | 1,171 | -74 | -11 | 58 | N/A |
6/30/2020 | 1,162 | -126 | -53 | 28 | N/A |
3/31/2020 | 1,194 | -139 | -78 | 10 | N/A |
12/31/2019 | 1,171 | -197 | -19 | 72 | N/A |
9/30/2019 | 1,074 | -201 | 14 | 91 | N/A |
6/30/2019 | 1,067 | -183 | 19 | 93 | N/A |
3/31/2019 | 1,092 | -173 | 74 | 148 | N/A |
12/31/2018 | 1,094 | -139 | 30 | 99 | N/A |
9/30/2018 | 1,054 | -139 | 5 | 75 | N/A |
6/30/2018 | 1,023 | -141 | -5 | 61 | N/A |
3/31/2018 | 937 | -152 | -54 | 6 | N/A |
12/31/2017 | 903 | -158 | -32 | 19 | N/A |
9/30/2017 | 842 | -169 | N/A | -9 | N/A |
6/30/2017 | 804 | -196 | N/A | -14 | N/A |
3/31/2017 | 781 | -200 | N/A | -20 | N/A |
12/31/2016 | 746 | -208 | N/A | -64 | N/A |
9/30/2016 | 695 | -257 | N/A | -69 | N/A |
6/30/2016 | 668 | -275 | N/A | -113 | N/A |
3/31/2016 | 624 | -274 | N/A | -100 | N/A |
12/31/2015 | 628 | -227 | N/A | -40 | N/A |
9/30/2015 | 640 | -127 | N/A | -29 | N/A |
6/30/2015 | 648 | -86 | N/A | -7 | N/A |
3/31/2015 | 650 | -36 | N/A | 17 | N/A |
12/31/2014 | 619 | -30 | N/A | 11 | N/A |
9/30/2014 | 598 | -42 | N/A | 36 | N/A |
6/30/2014 | 578 | -10 | N/A | 85 | N/A |
3/31/2014 | 563 | -7 | N/A | 89 | N/A |
12/31/2013 | 596 | 21 | N/A | 148 | N/A |
9/30/2013 | 578 | 19 | N/A | 136 | N/A |
6/30/2013 | 562 | 10 | N/A | 144 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 8AK's earnings are forecast to decline over the next 3 years (-15.5% per year).
Earnings vs Market: 8AK's earnings are forecast to decline over the next 3 years (-15.5% per year).
High Growth Earnings: 8AK's earnings are forecast to decline over the next 3 years.
Revenue vs Market: 8AK's revenue is expected to decline over the next 3 years (-2% per year).
High Growth Revenue: 8AK's revenue is forecast to decline over the next 3 years (-2% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 8AK's Return on Equity is forecast to be low in 3 years time (18.1%).